Skip to main content
TipRanks
Go Ultimate75% OFF

Immunovant (4YB) Revenue

0 Followers

Immunovant Revenue

Revenue (ttm)
7.09M
Revenue Growth
―
P/S Ratio
―
Revenue/Employee
EUR 0
Employees
315
Market Cap
EUR 6.66B

Revenue Chart

Immunovant Revenue - Annual

00.511.52201820192020202120222023202420252026
Revenue History
Download to Excel
DE:4YB revenue history
Fiscal End DateRevenueChangeGrowth
Mar 31, 20260.000.00―
Mar 31, 20250.000.00―
Mar 31, 20240.000.00―
Mar 31, 20230.000.00―
Mar 31, 20220.000.00―
Mar 31, 20210.000.00―
Mar 31, 20200.000.00―
Mar 31, 20190.000.00―
Mar 31, 20180.00――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
DE:4YB7.09M
TGTX897.76M
VRDN26.31M
AUPH321.74M
PTGX551.69M
KYMR102.22M